Skip to main content

Inhibikase Therapeutics, Inc.

IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001750149

No open-market purchases or sales by Inhibikase Therapeutics, Inc. insiders were filed in the last 90 days; 105 institutions reported holding it in 13F filings for Q2 2026, worth $239.2M in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Inhibikase Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
19
−4 vs. Q3 2022
Shares held
1.44M
−680.6K (−32.1%) vs. Q3 2022
Total value
$719.4K
−$1.21M (−62.7%) vs. Q3 2022
New holders
3
6 more added
Sold out
7
5 more reduced

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 19 institutions
Q1 2021: 9 institutionsQ2 2021: 14 institutionsQ3 2021: 21 institutionsQ4 2021: 26 institutionsQ1 2022: 24 institutionsQ2 2022: 22 institutionsQ3 2022: 24 institutionsQ4 2022: 19 institutionsQ1 2023: 17 institutionsQ2 2023: 14 institutionsQ3 2023: 13 institutionsQ4 2023: 11 institutionsQ1 2024: 12 institutionsQ2 2024: 12 institutionsQ3 2024: 11 institutionsQ4 2024: 31 institutionsQ1 2025: 47 institutionsQ2 2025: 48 institutionsQ3 2025: 54 institutionsQ4 2025: 74 institutionsQ1 2026: 104 institutionsQ2 2026: 105 institutions
Value heldQ4 2022: $719.4K
Q1 2021: $975.0KQ2 2021: $10.6MQ3 2021: $7.78MQ4 2021: $6.85MQ1 2022: $6.33MQ2 2022: $2.49MQ3 2022: $2.78MQ4 2022: $719.4KQ1 2023: $2.91MQ2 2023: $2.69MQ3 2023: $597.6KQ4 2023: $298.9KQ1 2024: $443.8KQ2 2024: $1.02MQ3 2024: $1.12MQ4 2024: $162.7MQ1 2025: $112.7MQ2 2025: $106.3MQ3 2025: $89.0MQ4 2025: $218.2MQ1 2026: $193.4MQ2 2026: $239.2M
Institutions holding IKT and their total value by quarter
QuarterHoldersValue
Q2 2026105$239.2M
Q1 2026104$193.4M
Q4 202574$218.2M
Q3 202554$89.0M
Q2 202548$106.3M
Q1 202547$112.7M
Q4 202431$162.7M
Q3 202411$1.12M
Q2 202412$1.02M
Q1 202412$443.8K
Q4 202311$298.9K
Q3 202313$597.6K
Q2 202314$2.69M
Q1 202317$2.91M
Q4 202219$719.4K
Q3 202224$2.78M
Q2 202222$2.49M
Q1 202224$6.33M
Q4 202126$6.85M
Q3 202121$7.78M
Q2 202114$10.6M
Q1 20219$975.0K

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Inhibikase Therapeutics, Inc.; share changes are against Q3 2022.

Institutions holding IKT in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc530,276$265.1K0.00%+1780.0%Added
Blair William & Co229,000$114.5K0.00%+50,000+27.9%Added
Redmond Asset Management, LLC125,805$62.9K0.02%+3,328+2.7%Added
Zeke Capital Advisors, LLC93,800$46.9K0.00%00.0%Unchanged
Geode Capital Management, LLC89,048$44.0K0.00%−178−0.2%Reduced
Koshinski Asset Management, Inc.65,377$32.7K0.00%00.0%Unchanged
State Street Corp60,500$30.3K0.00%00.0%Unchanged
Renaissance Technologies LLC52,000$26.0K0.00%−72,683−58.3%Reduced
Bank of New York Mellon Corp39,007$19.5K0.00%−305−0.8%Reduced
Retirement Planning Co of New England, Inc.35,212$17.6K0.01%−23,857−40.4%Reduced
Susquehanna International Group, LLP30,656$15.3K0.00%+30,656New
CCG Wealth Management, LLC30,000$15.0K0.01%+10,000+50.0%Added
Northern Trust Corp28,872$14.4K0.00%00.0%Unchanged
Morgan Stanley10,000$5.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)10,814$5.00K0.00%+4,648+75.4%Added
Sprott Inc.10,000$5.00K0.00%+10,000New
Wells Fargo & Company136$680.00%+4+3.0%Added
UBS Group AG130$650.00%−7,369−98.3%Reduced
Bank of America Corp40$200.00%+40New
FMR LLC0$00.00%−433,300−100.0%Sold out
Hamilton Lane Advisors LLC0$00.00%−165,635−100.0%Sold out
Citadel Advisors LLC0$00.00%−24,114−100.0%Sold out
K.J. Harrison & Partners Inc0$00.00%−18,300−100.0%Sold out
Millennium Management LLC0$00.00%−15,934−100.0%Sold out
Warberg Asset Management LLC0$00.00%−14,493−100.0%Sold out
StoneX Group Inc.0$00.00%−13,313−100.0%Sold out
ACT Capital Management, LLC––––Not filed